These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20155836)

  • 1. Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients.
    Perna M; Roman MJ; Alpert DR; Crow MK; Lockshin MD; Sammaritano L; Devereux RB; Cooke JP; Salmon JE
    Arthritis Rheum; 2010 Jun; 62(6):1718-22. PubMed ID: 20155836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
    Farzaneh-Far A; Roman MJ; Lockshin MD; Devereux RB; Paget SA; Crow MK; Davis A; Sammaritano L; Levine DM; Salmon JE
    Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ
    Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of asymptomatic hyperuricaemia and serum uric acid levels with arterial stiffness in women with systemic lupus erythematosus without clinically evident atherosclerotic cardiovascular disease.
    Sabio JM; Vargas-Hitos JA; Mediavilla JD; Navarrete-Navarrete N; Zamora-Posadas M; Pérez-Vicente S; Hidalgo-Tenorio C; Díaz-Chamorro A; Jáimez L; Jiménez-Alonso J;
    Lupus; 2010 Apr; 19(5):591-8. PubMed ID: 20179170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.
    de Leeuw K; Graaff R; de Vries R; Dullaart RP; Smit AJ; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2007 Oct; 46(10):1551-6. PubMed ID: 17848401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity.
    Kiani AN; Magder L; Petri M
    J Rheumatol; 2008 Jul; 35(7):1300-6. PubMed ID: 18484694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus.
    Selzer F; Sutton-Tyrrell K; Fitzgerald SG; Pratt JE; Tracy RP; Kuller LH; Manzi S
    Arthritis Rheum; 2004 Jan; 50(1):151-9. PubMed ID: 14730611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus.
    Shang Q; Tam LS; Li EK; Yip GW; Yu CM
    Lupus; 2008 Dec; 17(12):1096-102. PubMed ID: 19029277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench.
    Von Feldt JM
    Bull NYU Hosp Jt Dis; 2008; 66(3):184-7. PubMed ID: 18937629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between asymmetric dimethylarginine and neopterin in patients with and without angiographic coronary artery disease.
    Murr C; Meinitzer A; Grammer T; Schroecksnadel K; Böhm BO; März W; Fuchs D
    Scand J Immunol; 2009 Jul; 70(1):63-7. PubMed ID: 19522769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus.
    Bultink IE; Teerlink T; Heijst JA; Dijkmans BA; Voskuyl AE
    Ann Rheum Dis; 2005 Sep; 64(9):1362-5. PubMed ID: 16100343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum homocysteine and asymmetric dimethylarginine levels in patients with premature ovarian failure: a prospective controlled study.
    Gulhan I; Bozkaya G; Bilgir F; Kebapcilar L; Bilgir O; Kavrut M; Dogan E
    Gynecol Endocrinol; 2011 Aug; 27(8):568-71. PubMed ID: 20626241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus.
    Manzi S; Selzer F; Sutton-Tyrrell K; Fitzgerald SG; Rairie JE; Tracy RP; Kuller LH
    Arthritis Rheum; 1999 Jan; 42(1):51-60. PubMed ID: 9920014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients.
    Refai TM; Al-Salem IH; Nkansa-Dwamena D; Al-Salem MH
    Clin Rheumatol; 2002 Nov; 21(6):457-61. PubMed ID: 12447627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
    Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction.
    Maas R; Wenske S; Zabel M; Ventura R; Schwedhelm E; Steenpass A; Klemm H; Noldus J; Böger RH
    Eur Urol; 2005 Dec; 48(6):1004-11; discussion 1011-2. PubMed ID: 16139418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.